Subperiosteal Implants Provide Another Option for Dentistry: One Practitioner’s Experience

L. O’Roark

Full text link: https://pubmed.ncbi.nlm.nih.gov/9569874/

Subperiosteal Implants Provide Another Option for Dentistry: One Practitioner’s Experience

1. Scientific Reference

• Study title: Subperiosteal implants provide another option for dentistry: one practitioner’s experience
• Author: W. L. O’Roark
• PMID: 9569874
• Scientific journal: Not specified in the information provided.
• Year of publication: Not specified in the information provided.
• DOI: Not specified in the information provided.

2. Scientific Background

Restoring occlusal function in patients requiring implant-supported rehabilitation may involve different surgical and prosthetic strategies. In this publication, O’Roark focuses on the role of subperiosteal implants as one of the treatment options available within dental implantology.

Particular attention is given to the maxilla, which the author identifies as the more challenging of the two dental arches in his clinical experience. Within this setting, treatment planning may involve choosing between grafting procedures followed by endosseous implant placement and an approach incorporating a subperiosteal implant, potentially in combination with root-form implants.

The scientific interest of this paper therefore lies primarily in its assessment of a practitioner’s accumulated clinical experience rather than in a controlled comparison between implant protocols. The publication explores whether subperiosteal implant therapy can retain a place among the available approaches to complex implant rehabilitation.

3. Study Objective

The primary purpose of the paper was to examine the author’s clinical experience with a specific subperiosteal dental implant technique and to consider its role among alternative implant treatment strategies.

The analysis was based on information maintained in the author’s clinical database. Particular emphasis was placed on determining whether these accumulated data supported the continued consideration of subperiosteal implants as a therapeutic alternative, especially when managing the more challenging maxillary arch.

4. Methodology

The paper draws on data collected in a database maintained by the author, containing information on approximately 3,000 individual implants.

The available abstract refers to an “At Risk” computerized statistical analysis of this database. According to the author, the results of this analysis support the use of the subperiosteal implant as an alternative treatment approach.

However, several methodological details required for a comprehensive assessment are not reported in the information provided. These include the number of patients, patient selection criteria, distribution of implant types and locations, duration of follow-up, definitions of treatment success or failure, and detailed statistical methodology.

Consequently, the precise study design cannot be classified with confidence from the available abstract alone.

5. Main Results

The clinical experience reported in this publication supports the author’s view that subperiosteal implants may represent an alternative within dental implant treatment planning.

The maxilla is identified as presenting greater clinical challenges than the other arch. In this context, the author discusses different possible approaches, including grafting procedures combined with endosseous implants and treatment incorporating a subperiosteal implant, either alone within the proposed strategy or in combination with root-form implants.

The paper acknowledges that the available approaches each have advantages and disadvantages, although these are not characterized in detail in the abstract.

Importantly, the computerized statistical analysis of the author’s database is described as supporting the use of subperiosteal implants as an alternative. However, no specific implant survival rates, success rates, complication rates, comparative outcomes, or other quantitative clinical endpoints are provided in the available information.

6. Clinical Analysis

The principal clinical value of this publication lies in its examination of a substantial body of practitioner-generated implant data and its discussion of a treatment approach distinct from conventional endosseous implant placement associated with grafting procedures.

Rather than establishing the superiority of one technique, the paper presents subperiosteal implant therapy as an additional option within the treatment-planning process. This distinction is important. The information provided supports the author’s position that the technique can be considered an alternative, but it does not demonstrate that subperiosteal implants achieve better clinical outcomes than endosseous implants, graft-based rehabilitation, or any other implant strategy.

The emphasis placed on the maxilla also highlights the role of anatomical and therapeutic complexity when selecting an implant rehabilitation approach. The possibility of combining subperiosteal and root-form implants further suggests that the author considered different implant concepts potentially complementary rather than necessarily mutually exclusive.

Nevertheless, the clinical implications must be interpreted cautiously. Without detailed information on follow-up, complications, patient characteristics, outcome definitions, or comparative groups, the available data cannot establish long-term effectiveness or determine which patients would derive the greatest benefit from this approach.

7. Clinical Applications

Based strictly on the information provided, the study is primarily relevant to complex maxillary implant rehabilitation and to situations in which different surgical strategies are being considered.

The author’s experience places subperiosteal implant treatment alongside approaches involving bone grafting and endosseous implants. The paper also refers to a strategy combining subperiosteal implants with root-form implants, illustrating the potential consideration of different implant designs within a single rehabilitation concept.

However, the abstract does not provide sufficiently detailed clinical criteria to define specific indications or contraindications. It also does not identify particular degrees of bone deficiency, patient categories, or anatomical thresholds for selecting subperiosteal implant therapy. Such indications should therefore not be inferred from the available information.

8. Level of Evidence, Limitations, and Transparency

The evidence should be interpreted cautiously. The publication is based on a single practitioner’s clinical experience and analysis of a personally maintained implant database. The abstract does not describe randomization, a control group, or a prospective comparative protocol.

Although approximately 3,000 individual implants are represented in the database, the number of implants alone does not establish methodological strength. Essential information concerning the number of patients, follow-up period, outcome measures, patient selection, treatment distribution, and statistical methodology is not sufficiently detailed in the available abstract.

The methodological limitations are not explicitly described in the information provided. No author conflicts of interest or manufacturer affiliations are reported in the available material. This should not be interpreted as confirmation that none were disclosed in the full publication.

9. Key Study Points

• Study type: Practitioner-based clinical experience supported by analysis of a clinical implant database; exact methodological classification not specified.
• Level of evidence: Limited based on the methodological information available in the abstract.
• Population analyzed: Number of patients not specified in the information provided.
• Number of patients or implants: Approximately 3,000 individual implants recorded in the author’s database; number of patients not specified.
• Follow-up duration: Not specified in the information provided.
• Primary outcome: Not clearly defined in the available abstract.
• Main result: Statistical analysis of the author’s database is reported to support subperiosteal implants as an alternative treatment option.
• Scientific conclusion: The author’s clinical experience supports considering subperiosteal implants among the available implant rehabilitation strategies.
• Main limitations: Insufficient information regarding study design, patient population, follow-up duration, outcome definitions, complications, and quantitative comparative results.

10. Scientific Impact

The scientific contribution of this paper lies primarily in documenting clinical experience derived from a database containing approximately 3,000 individual implants and using these data to examine the potential role of subperiosteal implant therapy.

From an implant dentistry perspective, the publication contributes to the discussion of treatment alternatives for challenging rehabilitation, particularly in the maxilla. It also reflects an approach in which subperiosteal implants, endosseous implants, grafting procedures, and combined implant strategies are considered within the broader process of clinical decision-making.

Its scientific impact should nevertheless be interpreted according to the evidence available. The abstract does not provide the quantitative outcomes or methodological detail required to establish comparative effectiveness. The paper therefore provides clinical support for considering subperiosteal implants as an alternative rather than definitive evidence of superiority over other implant rehabilitation techniques.

11. Editorial Conclusion

O’Roark’s publication provides a clinically oriented perspective on the role of subperiosteal implants in dental implant rehabilitation, with particular attention to the challenges associated with the maxilla. The author’s database analysis supports considering this approach as an alternative among available implant strategies. However, the absence of detailed survival data, complication rates, follow-up duration, and clearly defined comparative outcomes substantially limits the strength of the conclusions that can be drawn. The findings should therefore be viewed as supportive clinical experience rather than definitive comparative evidence.